Literature DB >> 17934657

[Therapeutical approach of obesity in Prader-Willi Syndrome].

Daniel F de Carvalho1, Cíntia Cercato, Madson Q Almeida, Marcio C Mancini, Alfredo Halpern.   

Abstract

Prader-Willi Syndrome (PWS) is a multisystemic genetic disease characterized by hypotonia, mental retardation, characteristic facial appearance, hyperphagia, and compulsive eating due to hypothalamic dysfunction. PWS is caused by loss of function of genes located in chromosome 15q11-q13, an area subject to genomic imprinting. Obesity is a major cause of increased morbidity and mortality among patients with PWS. The objective of this study was to analyze the therapeutic options available for the treatment of the obesity in PWS including pharmacological and surgical strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934657     DOI: 10.1590/s0004-27302007000600004

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  1 in total

1.  A modified MS-PCR approach to diagnose patients with Prader-Willi and Angelman syndrome.

Authors:  Jéssica Fernandes Dos Santos; Laís R Mota; Pedro Henrique Silva Andrade Rocha; Renata Lúcia L Ferreira de Lima
Journal:  Mol Biol Rep       Date:  2016-08-17       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.